As of early 2023, over three million Aussies aged 14 and above were found to either smoke or vape. With a greater number of teens and young Aussies taking up vaping, it has created a massive potential market for cannabis cultivators and manufacturers like ECS Botanics (ASX: ECS). ECS is launching a range of GMP-certified
Read More
Once again, medical cannabis producer Vitura Health (ASX: VIT) has become the only ASX-listed company operating in the medicinal cannabis space to both generate a profit and declare a dividend since its ASX initiation in 2019. The Company will pay a dividend to shareholders in respect of FY23. The Dividend, which will be paid at
Read More
For anyone looking to cut down their coffee fix, they may soon have a natural alternative in the form of mushroom nootropics which acts as an even stronger cognitive stimulant than caffeine with manufacturer Bioxyne (ASX: BXN) making its first sales. The sale of Dr Watson products came via Amazon US where the mushroom nootropics
Read More
The medicinal cannabis industry in Australia has been rapidly gaining momentum, reaching an estimated value of approximately $245 million in 2022 and is projected to maintain a strong CAGR of 16.71% from 2023 to 2027. While the availability of cannabis for general use remains restricted in Australia, the nation continues to attract cannabis manufacturing companies
Read More
Since the easing of regulatory red tape and wider societal acceptance of utilising cannabis for its medical properties, the medicinal cannabis industry has become an intense battleground as researchers have raced towards commercial products. In the case of Cann Group (ASX: CAN) though, they might have just triggered a land mine. Undertaking any form of
Read More
A hot topic in medical research at the moment, medicinal cannabis studies are being carried out for seemingly any and all ailments. One such trial being run by the Murdoch Children’s Research Institute (MCRI) is extending efficacy studies of cannabidiol medicine to children with intellectual disability that exhibit severe behavioural problems. To facilitate these studies,
Read More